We are live on
!
Find out more
Aquestive Therapeutics
AQST
AQST
176 hedge funds and large institutions have $466M invested in Aquestive Therapeutics in 2025 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 68 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
114% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 21
79% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 38
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
26% more capital invested
Capital invested by funds: $369M → $466M (+$96.4M)
16% more funds holding
Funds holding: 152 → 176 (+24)
11% more call options, than puts
Call options by funds: $12.6M | Put options by funds: $11.4M
7.13% less ownership
Funds ownership: 66.24% → 59.11% (-7.1%)
Holders
176
Holders Change
+24
Holders Change %
+15.79%
% of All Funds
2.14%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
45
Increased
68
Reduced
38
Closed
21
Calls
$12.6M
Puts
$11.4M
Net Calls
+$1.27M
Net Calls Change
-$2.59M
Top Buyers
| 1 |
BlackRock
New York
|
+$7.79M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.78M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.19M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$6.59M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.05M |
